Product NewsNovozymes Biopharma and Millipore Launch First Animal-Free Product from Strategic Alliance
Product NewsNovozymes Biopharma Signs License Agreement with GE Healthcare to Produce and Sell Protein A
Product NewsNovozymes Grants Dyax Licences to its Albumin Fusion Technology, albufuse™ and Yeast-based Protein Expression Platform
Product NewsMillipore Corporation and Novozymes Form Strategic Alliance to Supply Animal-Free Cell Culture Supplements for Bioprocessing
Product NewsFirst European Product Containing Delta Biotechnology’s Recombumin® Receives Marketing Approval from the EMEA
Product NewsEMEA Adopts Positive Opinion on First European Product Containing Delta Biotechnology’s Recombumin® (recombinant human albumin)
